Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
NCT: NCT03617458 · COMPLETED
Brief Summary
The primary objective of this study is to determine the impact of two interventions against insulin resistance on the composite endpoint of 10% improvement in baseline six minute walk distance or improvement in World Health Organization (WHO) functional class in humans with pulmonary artery hypertension (PAH).
Frequently Asked Questions
What is Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension?
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension is a clinical trial registered under NCT03617458. Current status: COMPLETED.
What is the status of NCT03617458?
The current status of NCT03617458 (Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension) is: COMPLETED.
When did Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension start?
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension started on 2018-08-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.